Company news

ADMA Biologics Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection

July 19, 2021

ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference

June 13, 2021

ADMA Biologics to Participate in the Jefferies Virtual Healthcare Conference

May 25, 2021

ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments

May 11, 2021

ADMA Biologics to Report First Quarter 2021 Financial Results on May 12, 2021

May 4, 2021

ADMA Biologics Receives FDA Approval for Increased IVIG Production Scale

April 27, 2021

ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C.

April 25, 2021

ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting

April 12, 2021

ADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

March 24, 2021

ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

March 17, 2021

ADMA Biologics to Participate in the Jefferies Virtual Plasma Summit

March 3, 2021

ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections

March 2, 2021

ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting

February 25, 2021

ADMA Biologics to Participate in Raymond James Institutional Investor Conference

February 21, 2021

ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN

January 31, 2021

ADMA Biologics Receives Unique Permanent J-Code for ASCENIV™

January 25, 2021

ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic Outlook

January 18, 2021

ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV™

January 3, 2021

ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors

December 8, 2020

ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Maryville, TN

November 30, 2020

ADMA Biologics to Participate in Jefferies 2020 Virtual London Healthcare Conference

November 9, 2020

ADMA Biologics Reports Third Quarter 2020 Financial Results and Business Highlights

November 4, 2020

ADMA Biologics to Report Third Quarter 2020 Financial Results and Business Highlights on November 5, 2020

October 28, 2020

ADMA Biologics Announces Presentation on Respiratory Viral Infections and New Data on S. Pneumoniae at IDWeek 2020

October 20, 2020

ADMA Biologics to Participate in Morgan Stanley Virtual Healthcare Conference

September 8, 2020

ADMA Biologics Highlights Launch of COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay to Detect SARS-CoV-2 Neutralizing Antibodies in Plasma

September 2, 2020

ADMA Biologics to Participate in Upcoming Investor Conferences

September 1, 2020

ADMA Biologics Reports Business Highlights and Second Quarter 2020 Financial Results

August 4, 2020

ADMA Biologics to Report Business Highlights and Second Quarter 2020 Financial Results on August 5, 2020

July 28, 2020

ADMA Biologics Opens Its Newest ADMA BioCenters Plasma Collection Facility

July 5, 2020

ADMA Biologics Announces Martha J. Demski Elected to Board of Directors

June 22, 2020

ADMA Biologics to Participate in Jefferies Virtual Healthcare Conference

May 26, 2020

ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients

May 20, 2020

ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent Accomplishments

May 6, 2020

ADMA Biologics Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress

May 5, 2020

ADMA Biologics to Report First Quarter 2020 Financial Results on May 6, 2020

April 28, 2020

ADMA Biologics Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Company Progress

March 11, 2020

ADMA Biologics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020

March 4, 2020

ADMA Biologics Highlights Expanded Intellectual Property Portfolio for Specialty Plasma Derived Immune Globulins Targeted Against Respiratory Infections

March 2, 2020

ADMA Biologics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection with Its Public Offering of Common Stock

February 23, 2020

ADMA Biologics Receives BioNJ 2020 Innovator Award for ASCENIV™

February 10, 2020

ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock

February 5, 2020

ADMA Biologics Announces Pricing of Upsized $82.3 Million Public Offering of Common Stock

February 5, 2020

ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2019 Revenues and Provides 2020 Strategic Outlook

January 8, 2020

ADMA Biologics Enters Into a Manufacturing and Supply Agreement to Produce and Sell Plasma-Derived Intermediate Fractions

January 6, 2020

ADMA Biologics Added to NASDAQ Biotechnology Index

December 16, 2019

ADMA Biologics to Present at Jefferies 2019 London Healthcare Conference

November 12, 2019

ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress

November 5, 2019

ADMA Biologics Announces Acceptance to the Plasma Protein Therapeutics Association

November 3, 2019

ADMA Biologics Named Company of the Year by BioFlorida

October 21, 2019

← Newer news releases · Older news releases →

Calls

The 5 newest of 26 calls. Every call is listed under its year.

Decks

The 5 newest of 23 decks. Every deck is listed under its year.